Colibactin, Accelerated Aging, and the Cancer Surge Hitting Under-50s

Cancer has long been thought of as a disease that catches up with you in old age. That assumption is breaking down. Globally, new cancer diagnoses among people under 50 rose 79% between 1990 and 2019, and in Britain roughly 10,000 more adults under 50 are diagnosed each year compared with the 1990s. Two major studies, both funded through the Cancer Grand Challenges program, are now pointing toward two interlocking culprits: a bacterial toxin that may scar DNA in early childhood, and a generational shift toward faster biological aging.

Colibactin Mutations Found 3.3 Times More Often in Young Bowel Cancer Patients

The Mutographs team at the University of California San Diego sequenced 981 bowel cancer genomes from patients across 11 countries, hunting for mutational fingerprints that might explain why colorectal cancer has climbed from the fourth leading cause of cancer death in under-50s to number one in men and second in women in the US. What they found was a striking signal tied to colibactin, a toxin produced by certain strains of E. coli. The mutation patterns associated with colibactin, catalogued as SBS88 and ID18, were 3.3 times more common in bowel cancer patients under 40 than in those over 70.

The timing matters enormously. These colibactin-linked mutations appear to occur predominantly within the first ten years of life, when the gut microbiome is still forming and the bowel lining is especially vulnerable to DNA damage. As lead researcher Ludmil Alexandrov put it: "If someone acquires one of these driver mutations by the time they're 10 years old, they could be decades ahead of schedule for developing colorectal cancer, getting it at age 40 instead of 60." The bacteria responsible may be long gone by the time a tumor is diagnosed, but the genetic scars they leave behind remain. Alexandrov describes cancer sequencing as reading "an archeological record of everything that happened in that person's lifetime."

Western diets heavy in processed meat, sugar, and refined grains appear to encourage the growth of colibactin-producing E. coli strains, which may partly explain why early-onset colorectal cancer increased by 7.9% per year among 20-to-29-year-olds across 20 European countries between 1990 and 2016. Today, one in five colorectal cancer cases is diagnosed in someone younger than 54.

Accelerated Biological Aging Raises Risk for Several Early-Onset Cancers

A separate team at Washington University School of Medicine in St. Louis took a different angle. Analyzing health data from more than 164,000 individuals in the UK Biobank and 10,000 from the US, they found that younger generations are showing signs of biologically faster aging than their predecessors at the same chronological age. Biological age, which reflects the actual condition of the body's tissues and organs rather than years lived, is a meaningful risk signal: a larger gap between biological and chronological age correlates with higher risk of developing cancer earlier in life.

The association was particularly strong for early-onset lung, gastrointestinal, and uterine cancers. Researchers pointed to a cluster of modern lifestyle factors as likely contributors: obesity, ultra-processed diets, sedentary behavior, environmental pollution, chronic inflammation, and long-term stress. It is worth being precise about what this means and what it does not. Accelerated biological aging does not directly cause cancer in any simple mechanical sense; the relationship is correlational, and the precise drivers of faster aging in younger cohorts are not yet definitively established.

How Researchers Isolated These Signals Across Populations

Both studies are notable for their scale. The Mutographs genome analysis drew on 981 tumor samples spanning 11 countries, giving it cross-national reach unusual in this field. The mutation patterns SBS88 and ID18 appeared consistently across populations, suggesting a shared biological mechanism rather than a local dietary quirk. The Washington University team used two independent cohorts, the UK Biobank and a US dataset, which allowed them to test whether the biological aging signal replicated across different health systems and demographic groups.

The unique pressures facing younger cancer patients, including fertility decisions, career disruption, and altered life trajectories, add urgency to this research. Identifying who is at elevated risk before a tumor develops is considerably more valuable than identifying it afterward.

Open Questions About Causality and What Triggers Faster Aging

Neither study delivers a complete explanation for the early-onset cancer surge. The colibactin hypothesis is compelling but preliminary: researchers do not yet know how many people carry these mutation signatures, what proportion will go on to develop cancer, or whether any intervention in childhood could prevent the damage from accumulating. It also remains unclear why some individuals exposed to colibactin-producing E. coli develop lasting mutations while others do not.

On the biological aging side, the field still lacks consensus on which specific exposures are most responsible for accelerating the aging clock in younger generations. Obesity and ultra-processed food are plausible candidates, but establishing causation rather than correlation requires longer prospective studies. As David Scott, one of the researchers involved, noted, studies like these are "helping us piece together the bigger picture, showing that cancer may be influenced not just by changes inside individual cells, but by wider changes happening across the body as a whole."

Earlier Detection and Microbiome Intervention as Next Steps

Both research teams see their findings as pointing toward concrete prevention and detection opportunities. If colibactin mutations can be identified through stool tests or blood-based genomic screening early in life, it may become possible to flag individuals who are decades ahead of the usual cancer schedule and bring forward surveillance accordingly. The 79% global rise in under-50s cancer cases documented in the BMJ Oncology research makes that kind of early detection framework more urgent than it might have seemed a generation ago.

On the biological aging front, the Nature Medicine findings suggest that measures of accelerated aging could in principle be used to identify high-risk individuals before symptoms emerge. Whether that translates into a clinical tool in the near term depends on replication in larger cohorts and on identifying which aging biomarkers are most predictive. For now, the two studies together represent the most coherent framework yet for explaining why cancer is increasingly a disease of people in their 30s and 40s, not just their 60s and 70s.

Evidence rating

INVESTIGATIONAL — 65/100

Caveats:

• This is a journalistic article, not a peer-reviewed study — claims are sourced from expert quotes rather than original data.
• No funding or primary study data is disclosed; assertions cannot be independently verified from this source alone.
• The link between gut microbiome changes and early-onset cancer is described as 'emerging evidence' — causation has not been established.

This is a journalistic article rather than a primary research study, drawing on expert commentary rather than original data or a defined study design. No sample, statistical analysis, or peer-reviewed methodology is presented, so no causal or associative conclusions can be assessed. The claims about gut flora and early-onset cancer reflect emerging scientific hypotheses that have not been consolidated into replicated, peer-reviewed findings within this source.

References

1. (2026). Age fast, get cancer young: the 'global surge' hitting under-50s – The Times. https://www.thetimes.com/life-style/health-fitness/article/cancer-rise-in-young-adults-explained-f8p5wzm2l
2. Global surge in cancers among the under 50s over past three decades – BMJ Group. The BMJ. https://bmjoncology.bmj.com/content/2/1/e000040
3. Ruiyi Tian, Xiaoyu Zong, Duo Ren, et al. (2026). Biological aging and generational shifts in early-onset cancer risk. Nature Medicine. https://doi.org/10.1038/s41591-026-04448-w
4. F. André, E. Rassy, B. Achutti-Duso, et al. (2025). The rising tides of cancers among young adults. ESMO Open. https://doi.org/10.1016/j.esmoop.2025.105553